Skip to main content
. 2022 Mar 19;74(5):1763–1771. doi: 10.1007/s13304-022-01243-3

Table 3.

Periioperative data

Postoperative course MDR-O SSI (N: 47 [%]) Non MDR-O SSI (N: 47 [%]) Mult. analysis OR (CI 95%) Sig
Minor complications C–D 0/I–II 0/19 [40.4%] 0/42 [89.3%] 5.373 (1.59; 18.13) 0.007
Major complications° C–D III–V 28 [59.5%]§§,** 5 [10.6%]
General complications
 Cardiovascular 3 (6.8%) 0 0.084
 Respiratory 11 (23.4%)§
Surgical complications
 Hemorrhage 5 [10.6%] 4 [8.5%] 0.149
 Dehiscence 16 [34%]§ 3 [6.3%]
Infectious complications
 Superficial SSI 20 [42.5%] 25 [53.1%] 0.052
 Deep SSI 11 [23.4%] 19 [40.4%]
 Organ/Space SSI 16 [34%]§ 3 [6.38%]
Pneumonitis 5 [10.6%] 0 0.087
CLABSI 7 [14.8%] 5 [10.6%]
CAUTI 10 [21.8%] 5 [10.6%]
Septic evolution qSOFA > 2 47[100%]§§ 17 [36.1%] 0.072
Septic shock 13 [27.6%]§ 2 [4.2%] 0.373
Multi organ failure 6 [12.7%]§ 0 0.270
Multi-microbic infection with C–D III–V 12 [25.5]§ 1 [2.13%] 0.335
Reoperation rate 20 [42.5%]§§ 1[2.1%] 12.2 (1.37; 109.2) 0.025
ICU admission 20 [42.5%]§§ 5 [10.6%] 0.2
ICU stay (days) 12.8 ± 15.9§ 1.2 ± 0.45
Total postoperative course 38.1 ± 22§§,** 16.1 ± 7.3*
Total hospital stay 47.8 ± 42§§,** 18.36 ± 8.2*

CLABSI central line-associated bloodstream infections, CAUTI catheter associated urinary tract infection, qSOFA quick score for sepsis, ICU intensive care unit

*p < 0.05 vs No SSI. **p < 0.01 vs No SSI. §p < 0.05 vs non-MDR-O SSI. §§p < 0.01 vs non-MDR-O SSI